摘要
目的:分析广东2008-2013年期间药品价格水平的变化情况,探讨广东2009年开始改革药品价格的成效。方法:收集广东省医药采购平台的药品采购数据和广东省物价部门针对药品价格"三控"管理政策的调研数据,采用固定拉氏价格指数和医院用药结构分析等方法,结合相关政策进行数据处理和对比分析。结果:广东省抗微生物、抗肿瘤、消化系统、神经系统和循环系统五大类药品在医药价格改革后的2009-2013年期间价格水平整体低于2008年,其中抗微生物类药物的价格水平下降幅度最大;大多数用量较大的药品价格下降,药品价格较低的品种使用量增加,药品价格较高的品种使用量大幅度下降。结论:广东医药价格改革在控制药品价格水平、改变用药结构和降低患者费用负担等方面取得一定的成效。
Objective: To analyze the changes in medicine price levels from 2008 to 2013 in Guangdong province, and evaluate the effect of Guangdong medicine price reform since 2009. Methods: We collected medi- cine procurement data from the medicine procurement platform of Guangdong province, and the investigation data of the three-control policy on medicine price conducted by the commodity price department of Guangdong province. Based on the L-Price Index and hospital medication structure analysis, we analyzed the data combined with related policy. Results: The overall price levels of antimicrobial, antitumor, digestive system, nervous system and circulatory system drugs from 2009 to 2013 were lower than that in 2008, and the price level of antimicrobial drugs declined largest. The prices of most of the frequently used drugs declined. The usage of lower-price drugs increased while that of higher-price drugs decreased greatly. Conclusion: Guangdong medicine price reform has made certain achievements in controlling the medicine price levels, changing the medication structure and reducing the burden of patients.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2015年第8期861-864,共4页
Chinese Journal of New Drugs
关键词
医药价格改革
药品价格
差别定价
药品价格“三控”管理
拉氏价格指数
用药结构
medicine price reform
medicine price
differential pricing
the three-control policy on medi- cine price
L-Price Index
medication structure